Suppr超能文献

甲状腺微小乳头状癌的高细胞型变体:BRAF(V600E)基因突变分析的临床病理特征。

Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.

机构信息

1 Department of Pathology, Yale School of Medicine , New Haven, Connecticut.

出版信息

Thyroid. 2013 Dec;23(12):1525-31. doi: 10.1089/thy.2013.0154. Epub 2013 Sep 3.

Abstract

BACKGROUND

The tall cell variant of papillary thyroid carcinoma is an aggressive subtype that generally presents as a large tumor in the advanced stage; however, little is known about the tall cell variant of microcarcinoma (tumors measuring <1 cm). In this study, we compare the tall cell variant of microcarcinoma (microTCV) with classic papillary microcarcinomas to examine the hypothesis that, despite the small size, the microTCV may be more aggressive than the classic papillary microcarcinoma.

METHODS

We identified 27 microTCV patients and compared their clinicopathologic features and BRAF(V600E) mutational status with classic papillary microcarcinomas matched by age and size. The patients with microTCV included 22 women and 5 men aged 33 to 74 years (median age, 56 years). All patients underwent total thyroidectomy; 20 patients had lymph node dissection.

RESULTS

Tumor size in microTCV patients ranged from 2 mm to 10 mm (median, 7 mm). Extrathyroidal extension and lymphovascular invasion were seen in 9 (33%) and 4 (15%) tumors, respectively. Thirteen patients (48%) harbored multifocal papillary carcinomas. Metastasis to central compartment lymph nodes was seen in 8 patients and to lateral cervical nodes in 3 patients. Nine of the 25 patients (36%) presented at an advanced stage (stage III/IVA). The BRAF(V600E) mutation was detected in 25 of 27 tumors (92.6%). In contrast, age- and size-matched classic papillary microcarcinomas (n=26) showed no extrathyroidal extension (p=0.002), lymphovascular invasion in 1, central compartment lymph node metastasis in 2, lateral cervical node metastasis in 1, multifocal tumors in 10 (38.5%), the BRAF(V600E) mutation in 20 (76.9%), and it infrequently presented in stage III/IVA (7.7%, p=0.02).

CONCLUSIONS

The microTCV form is associated with aggressive features at presentation, and it should be differentiated from other papillary thyroid microcarcinomas.

摘要

背景

甲状腺乳头状癌的 tall cell 变体是一种侵袭性亚型,通常表现为晚期的大肿瘤;然而,对于微癌(<1cm 的肿瘤)的 tall cell 变体知之甚少。在这项研究中,我们比较了微癌的 tall cell 变体(microTCV)与经典的甲状腺乳头状微癌,以检验这样一种假设,即尽管肿瘤较小,但 microTCV 可能比经典的甲状腺乳头状微癌更具侵袭性。

方法

我们鉴定了 27 例 microTCV 患者,并将其临床病理特征和 BRAF(V600E)突变状态与年龄和大小匹配的经典甲状腺乳头状微癌进行比较。microTCV 患者包括 22 名女性和 5 名男性,年龄 33-74 岁(中位年龄 56 岁)。所有患者均接受了全甲状腺切除术;20 例患者进行了淋巴结清扫术。

结果

microTCV 患者的肿瘤大小为 2-10mm(中位大小为 7mm)。9 例(33%)肿瘤有甲状腺外侵犯,4 例(15%)肿瘤有血管淋巴管侵犯。13 例(48%)患者有多个局灶性乳头状癌。8 例患者中央区淋巴结转移,3 例患者侧颈部淋巴结转移。25 例患者中有 9 例(36%)为晚期(III/IVA 期)。27 例肿瘤中有 25 例(92.6%)检测到 BRAF(V600E)突变。相比之下,年龄和大小匹配的经典甲状腺乳头状微癌(n=26)无甲状腺外侵犯(p=0.002),1 例有血管淋巴管侵犯,2 例有中央区淋巴结转移,1 例有侧颈部淋巴结转移,10 例(38.5%)有多个肿瘤,20 例(76.9%)有 BRAF(V600E)突变,且很少出现 III/IVA 期(7.7%,p=0.02)。

结论

microTCV 形式与表现出的侵袭性特征有关,应与其他甲状腺乳头状微癌相区别。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验